TEYA SUPPORT SERVICES LLC: $11.8M Department of Health and Human Services Contract
Summary
This $11.8M contract from the National Institutes of Health to Teya Support Services LLC for CC EVS service and supply is a moderate-sized award to a private entity. No publicly traded companies are directly linked, and the impact on the healthcare sector is limited.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Contract recipient is private, so no public tickers are affected.
- 2.Healthcare sector legislation is neutral to bullish but not directly tied to this award.
- 3.Investors should monitor future NIH awards to larger public companies for clearer signals.
Market Implications
No direct market implications from this contract due to the private recipient. The healthcare sector may see indirect support from related bills like HR8875, but this award alone does not move any publicly traded stock.
Full Analysis
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
SAPIENT GOVERNMENT SERVICES, INC.: $10.8M Department of Health and Human Services Contract
Improving Home Dialysis Act of 2026
SAWTOOTH CONSTRUCTION JV II LLC: $18.0M Department of Veterans Affairs Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.
Accelerating Medical Treatments for Serious Mental Illness
This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.
Contract Details
Recipient
TEYA SUPPORT SERVICES LLC
Award Amount
$11,788,074
Awarding Agency
Department of Health and Human Services
Sub-Agency
National Institutes of Health
Contract Type
BPA CALL
Related Bills